Published : Mar 2019
Tables : 71
Figures : 65
Category : Pharmaceuticals and Healthcare
No. of Pages : 157
Report Code : LI_17454
"According to a new report published by Allied Market Research, titled,""Medical Tourism Market by Treatment Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the market was valued at $53,768 million in 2017, and is projected to reach $143,461 million by 2025, growing at a CAGR of 12.9% from 2018 to 2025. The process of traveling outside the country of residence to avail medical treatment and care is known as medical tourism. Medical tourists avail of different treatments such as cancer treatment, cardiovascular treatment, neurological treatment, fertility treatment, and others. The escalation in healthcare costs associated with developed countries has forced individuals to look for affordable alternatives. This boosts the growth of the medical tourism market. Affordability, availability, and accessibility of good quality healthcare services coupled with support and assistance from tourism departments & local governments fuel the market growth. In addition, the increase in the incidence of cancer and other serious ailments is anticipated to drive the demand for healthcare services, which in turn is expected to boost the growth of the medical tourism market. Limited coverage and lengthy partial reimbursement offered by insurance companies along with difficulties associated with cross border travel, such as language barriers, connectivity, documentation, and VISA approval issues, are projected to impede market growth. Conversely, wider hospital network underinsurance coverage for cashless transactions serves as an opportunity for the growth of the medical tourism market. Based on treatment type, the cancer treatment segment accounted for the highest market share in 2017 due to the surge in the incidence of cancer worldwide. This is projected to increase the number of cross-border travelers seeking good quality cancer treatment. In addition, cancer treatment is an expensive and prolonged treatment, hence reduced cost of treatment in different countries fuels the growth of the market. Furthermore, due to the lack of availability of advanced treatment in some countries, patients choose to travel to other countries that offer advanced healthcare facilities. Key Findings of the Medical Tourism Market: + North America occupied nearly one-third share of the global medical tourism market in 2017. + The cancer treatment segment is anticipated to grow with the highest CAGR throughout the forecast period. + The cosmetic treatment segment accounted for around two-fifths share of the market in 2017. + Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA. North America accounted for the highest market share due to recent joint commission international (JCI) accreditations to hospitals (JCI accreditation is considered the gold standard in global health care), which makes them a preferred choice for medical tourists. In addition, advanced specialized treatments for cancer, neurological, and cardiovascular ailments also serves as a growth factor for the medical tourism market in North America. Asia-Pacific possesses the highest market potential due to the availability of good quality care at a cost of less than 70% of the cost of services in North America. In addition, significant investments by the government to improve healthcare infrastructure also contributes toward the growth of this market. The report provides an extensive competitive analysis and profiles of the key market players such as Apollo Hospitals Enterprise Limited; Fortis Healthcare Limited; Asian Heart Institute; KPJ Healthcare Berhad; NTT Medical Center Tokyo; Seoul National University Hospital, UZ Leuven, Wooridul Spine Hospital, Aditya Birla Memorial Hospital, Barbados Fertility Center, Prince Court Medical Centre, and Samitivej PCL. About Us: Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry."
"According to a new report published by Allied Market Research, titled,""Medical Tourism Market by Treatment Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the market was valued at $53,768 million in 2017, and is projected to reach $143,461 million by 2025, growing at a CAGR of 12.9% from 2018 to 2025.
The process of traveling outside the country of residence to avail medical treatment and care is known as medical tourism. Medical tourists avail of different treatments such as cancer treatment, cardiovascular treatment, neurological treatment, fertility treatment, and others. The escalation in healthcare costs associated with developed countries has forced individuals to look for affordable alternatives. This boosts the growth of the medical tourism market.
Affordability, availability, and accessibility of good quality healthcare services coupled with support and assistance from tourism departments & local governments fuel the market growth. In addition, the increase in the incidence of cancer and other serious ailments is anticipated to drive the demand for healthcare services, which in turn is expected to boost the growth of the medical tourism market. Limited coverage and lengthy partial reimbursement offered by insurance companies along with difficulties associated with cross border travel, such as language barriers, connectivity, documentation, and VISA approval issues, are projected to impede market growth. Conversely, wider hospital network underinsurance coverage for cashless transactions serves as an opportunity for the growth of the medical tourism market.
Based on treatment type, the cancer treatment segment accounted for the highest market share in 2017 due to the surge in the incidence of cancer worldwide. This is projected to increase the number of cross-border travelers seeking good quality cancer treatment. In addition, cancer treatment is an expensive and prolonged treatment, hence reduced cost of treatment in different countries fuels the growth of the market. Furthermore, due to the lack of availability of advanced treatment in some countries, patients choose to travel to other countries that offer advanced healthcare facilities.
Key Findings of the Medical Tourism Market:
+ North America occupied nearly one-third share of the global medical tourism market in 2017. + The cancer treatment segment is anticipated to grow with the highest CAGR throughout the forecast period. + The cosmetic treatment segment accounted for around two-fifths share of the market in 2017. + Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
North America accounted for the highest market share due to recent joint commission international (JCI) accreditations to hospitals (JCI accreditation is considered the gold standard in global health care), which makes them a preferred choice for medical tourists. In addition, advanced specialized treatments for cancer, neurological, and cardiovascular ailments also serves as a growth factor for the medical tourism market in North America. Asia-Pacific possesses the highest market potential due to the availability of good quality care at a cost of less than 70% of the cost of services in North America. In addition, significant investments by the government to improve healthcare infrastructure also contributes toward the growth of this market.
The report provides an extensive competitive analysis and profiles of the key market players such as Apollo Hospitals Enterprise Limited; Fortis Healthcare Limited; Asian Heart Institute; KPJ Healthcare Berhad; NTT Medical Center Tokyo; Seoul National University Hospital, UZ Leuven, Wooridul Spine Hospital, Aditya Birla Memorial Hospital, Barbados Fertility Center, Prince Court Medical Centre, and Samitivej PCL. About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry."
CHAPTER 1: INTRODUCTION 1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments 1.3.1. List of key players profiled in the report 1.4. Research methodology 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models CHAPTER 2: EXECUTIVE SUMMARY 2.1. Key findings of the study 2.2. CXO perspective CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.3. Top winning strategies 3.4. Reimbursement scenario 3.4.1. Developed regions 3.4.2. Developing regions 3.5. Government regulations 3.6. Top player positioning, 2017 3.7. Porters five forces analysis 3.8. Market dynamics 3.8.1. Drivers 3.8.1.1. Affordable good quality care 3.8.1.2. Availability of quality care 3.8.1.3. Accessible information and care 3.8.1.4. Assistance and support from government agencies and associations 3.8.2. Restraints 3.8.2.1. Limited coverage and lengthy partial reimbursement by payers 3.8.2.2. Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues 3.8.3. Opportunities 3.8.3.1. Overseas promotional offices is a key source of medical tourists 3.8.3.2. Wider hospital network under insurance coverage for cashless transactions 3.8.4. Impact analyses CHAPTER 4: MEDICAL TOURISM MARKET, BY TREATMENT TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Dental Treatment 4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast, by region 4.3. Cosmetic Treatment 4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast, by region 4.4. Cardiovascular treatment 4.4.1. Key market trends, growth factors, and opportunities 4.4.2. Market size and forecast, by region 4.5. Orthopedic treatment 4.5.1. Key market trends, growth factors, and opportunities 4.5.2. Market size and forecast, by region 4.6. Neurological treatment 4.6.1. Key market trends, growth factors, and opportunities 4.6.2. Market size and forecast, by region 4.7. Cancer treatment 4.7.1. Key market trends, growth factors, and opportunities 4.7.2. Market size and forecast, by region 4.8. Fertility treatment 4.8.1. Key market trends, growth factors, and opportunities 4.8.2 Market size and forecast, by region 4.9. Other treatments 4.9.1. Key market trends, growth factors, and opportunities 4.9.2. Market size and forecast, by region CHAPTER 5: MEDICAL TOURISM MARKET, BY REGION 5.1. Overview 5.1.1. Market size and forecast 5.2. North America 5.2.1. Key market trends, growth factors, and opportunities 5.2.2. Market size and forecast, by country 5.2.3. Market size and forecast, by treatment type 5.2.3.1. U.S. market size and forecast 5.2.3.2. Canada market size and forecast 5.2.3.3. Mexico market size and forecast 5.3. Europe 5.3.1. Key market trends, growth factors, and opportunities 5.3.2. Market size and forecast, by country 5.3.3. Market size and forecast, by treatment type 5.3.3.1. UK market size and forecast 5.3.3.2. Germany market size and forecast 5.3.3.3. France market size and forecast 5.3.3.4. Italy market size and forecast 5.3.3.5. Spain market size and forecast 5.3.3.6. Rest of Europe market size and forecast 5.4. Asia-Pacific 5.4.1. Key market trends, growth factors, and opportunities 5.4.2. Market size and forecast, by country 5.4.3. Market size and forecast, by treatment type 5.4.3.1. India market size and forecast 5.4.3.2. China market size and forecast 5.4.3.3. Indonesia market size and forecast 5.4.3.4. Singapore market size and forecast 5.4.3.5. Malaysia market size and forecast 5.4.3.6. Thailand market size and forecast 5.4.3.7. South Korea market size and forecast 5.4.3.8. Taiwan market size and forecast 5.4.3.9. Rest of Europe market size and forecast 5.5. LAMEA 5.5.1. Key market trends, growth factors, and opportunities 5.5.2. Market size and forecast, by country 5.5.3. Market size and forecast, by treatment type 5.5.3.1. Brazil market size and forecast 5.5.3.2. Venezuela market size and forecast 5.5.3.3. Costa Rica market size and forecast 5.5.3.4. UAE market size and forecast 5.5.3.5. South Africa market size and forecast 5.5.3.6. Rest of Europe market size and forecast CHAPTER 6: COMPANY PROFILES 6.1. Apollo Hospitals Enterprise Limited 6.1.1. Company overview 6.1.2. Company snapshot 6.1.3. Operating business segments 6.1.4. Product portfolio 6.1.5. Business performance 6.1.6. Key strategic moves and developments 6.2. FORTIS HEALTHCARE LIMITED 6.2.1. Company overview 6.2.2. Company snapshot 6.2.3. Operating business segments 6.2.4. Product portfolio 6.2.5. Business performance 6.3. Asian Heart Institute 6.3.1. Company overview 6.3.2. Company snapshot 6.3.3. Operating business segments 6.3.4. Product portfolio 6.4. Kpj Healthcare Berhad 6.4.1. Company overview 6.4.2. Company snapshot 6.4.3. Operating business segments 6.4.4. Product portfolio 6.4.5. Business performance 6.4.6. Key strategic moves and developments 6.5. NTT Medical Center Tokyo 6.5.1. Company overview 6.5.2. Company snapshot 6.5.3. Operating business segments 6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL. 6.6.1. Company overview 6.6.2. Company snapshot 6.6.3. Operating business segments 6.6.4. Product portfolio 6.7. UZ Leuven 6.7.1. Company overview 6.7.2. Company snapshot 6.7.3. Operating business segments 6.7.4. Product portfolio 6.8. Wooridul Spine Hospital 6.8.1. Company overview 6.8.2. Company snapshot 6.8.3. Product Portfolio 6.9. Aditya Birla Memorial Hospital 6.9.1. Company overview 6.9.2. Company snapshot 6.9.3. Operating business segments 6.9.4. Product portfolio 6.10. Barbados Fertility Center 6.10.1. Company overview 6.10.2. Company snapshot 6.10.3. Operating business segments 6.10.4. Product portfolio 6.11. Prince Court Medical Centre 6.11.1. Company overview 6.11.2. Company snapshot 6.11.3. Operating business segments 6.11.4. Product portfolio 6.12. Samitivej PCL. 6.12.1. Company overview 6.12.2. Company snapshot 6.12.3. Operating business segments 6.12.4. Product portfolio
CHAPTER 1: INTRODUCTION
1.1. Report description 1.2. Key benefits for stakeholders 1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study 2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope 3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies 3.4. Reimbursement scenario
3.4.1. Developed regions 3.4.2. Developing regions
3.5. Government regulations 3.6. Top player positioning, 2017 3.7. Porters five forces analysis 3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Affordable good quality care 3.8.1.2. Availability of quality care 3.8.1.3. Accessible information and care 3.8.1.4. Assistance and support from government agencies and associations
3.8.2. Restraints
3.8.2.1. Limited coverage and lengthy partial reimbursement by payers 3.8.2.2. Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues
3.8.3. Opportunities
3.8.3.1. Overseas promotional offices is a key source of medical tourists 3.8.3.2. Wider hospital network under insurance coverage for cashless transactions
3.8.4. Impact analyses
CHAPTER 4: MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Dental Treatment
4.2.1. Key market trends, growth factors, and opportunities 4.2.2. Market size and forecast, by region
4.3. Cosmetic Treatment
4.3.1. Key market trends, growth factors, and opportunities 4.3.2. Market size and forecast, by region
4.4. Cardiovascular treatment
4.4.1. Key market trends, growth factors, and opportunities 4.4.2. Market size and forecast, by region
4.5. Orthopedic treatment
4.5.1. Key market trends, growth factors, and opportunities 4.5.2. Market size and forecast, by region
4.6. Neurological treatment
4.6.1. Key market trends, growth factors, and opportunities 4.6.2. Market size and forecast, by region
4.7. Cancer treatment
4.7.1. Key market trends, growth factors, and opportunities 4.7.2. Market size and forecast, by region
4.8. Fertility treatment
4.8.1. Key market trends, growth factors, and opportunities 4.8.2 Market size and forecast, by region
4.9. Other treatments
4.9.1. Key market trends, growth factors, and opportunities 4.9.2. Market size and forecast, by region
CHAPTER 5: MEDICAL TOURISM MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities 5.2.2. Market size and forecast, by country 5.2.3. Market size and forecast, by treatment type
5.2.3.1. U.S. market size and forecast 5.2.3.2. Canada market size and forecast 5.2.3.3. Mexico market size and forecast
5.3. Europe
5.3.1. Key market trends, growth factors, and opportunities 5.3.2. Market size and forecast, by country 5.3.3. Market size and forecast, by treatment type
5.3.3.1. UK market size and forecast 5.3.3.2. Germany market size and forecast 5.3.3.3. France market size and forecast 5.3.3.4. Italy market size and forecast 5.3.3.5. Spain market size and forecast 5.3.3.6. Rest of Europe market size and forecast
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors, and opportunities 5.4.2. Market size and forecast, by country 5.4.3. Market size and forecast, by treatment type
5.4.3.1. India market size and forecast 5.4.3.2. China market size and forecast 5.4.3.3. Indonesia market size and forecast 5.4.3.4. Singapore market size and forecast 5.4.3.5. Malaysia market size and forecast 5.4.3.6. Thailand market size and forecast 5.4.3.7. South Korea market size and forecast 5.4.3.8. Taiwan market size and forecast 5.4.3.9. Rest of Europe market size and forecast
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities 5.5.2. Market size and forecast, by country 5.5.3. Market size and forecast, by treatment type
5.5.3.1. Brazil market size and forecast 5.5.3.2. Venezuela market size and forecast 5.5.3.3. Costa Rica market size and forecast 5.5.3.4. UAE market size and forecast 5.5.3.5. South Africa market size and forecast 5.5.3.6. Rest of Europe market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Apollo Hospitals Enterprise Limited
6.1.1. Company overview 6.1.2. Company snapshot 6.1.3. Operating business segments 6.1.4. Product portfolio 6.1.5. Business performance 6.1.6. Key strategic moves and developments
6.2. FORTIS HEALTHCARE LIMITED
6.2.1. Company overview 6.2.2. Company snapshot 6.2.3. Operating business segments 6.2.4. Product portfolio 6.2.5. Business performance
6.3. Asian Heart Institute
6.3.1. Company overview 6.3.2. Company snapshot 6.3.3. Operating business segments 6.3.4. Product portfolio
6.4. Kpj Healthcare Berhad
6.4.1. Company overview 6.4.2. Company snapshot 6.4.3. Operating business segments 6.4.4. Product portfolio 6.4.5. Business performance 6.4.6. Key strategic moves and developments
6.5. NTT Medical Center Tokyo
6.5.1. Company overview 6.5.2. Company snapshot 6.5.3. Operating business segments
6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL.
6.6.1. Company overview 6.6.2. Company snapshot 6.6.3. Operating business segments 6.6.4. Product portfolio
6.7. UZ Leuven
6.7.1. Company overview 6.7.2. Company snapshot 6.7.3. Operating business segments 6.7.4. Product portfolio
6.8. Wooridul Spine Hospital
6.8.1. Company overview 6.8.2. Company snapshot 6.8.3. Product Portfolio
6.9. Aditya Birla Memorial Hospital
6.9.1. Company overview 6.9.2. Company snapshot 6.9.3. Operating business segments 6.9.4. Product portfolio
6.10. Barbados Fertility Center
6.10.1. Company overview 6.10.2. Company snapshot 6.10.3. Operating business segments 6.10.4. Product portfolio
6.11. Prince Court Medical Centre
6.11.1. Company overview 6.11.2. Company snapshot 6.11.3. Operating business segments 6.11.4. Product portfolio
6.12. Samitivej PCL.
6.12.1. Company overview 6.12.2. Company snapshot 6.12.3. Operating business segments 6.12.4. Product portfolio
Table 01. Cost comparison of selected medical procedures in major medical tourism destinations, 2018 (usd) Table 02. Global medical tourism market, by treatment type, 20172025 ($million) Table 03. Global medical tourism market, by treatment type, 20172025 (number of patients in thousands) Table 04. Medical tourism market for dental treatment, by region, 20172025 ($million) Table 05. Medical tourism market for dental treatment, by region, 20172025 (number of patients in thousands) Table 06. Medical tourism market for cosmetic treatment, by region, 20172025 ($million) Table 07. Medical tourism market for cosmetic treatment, by region, 20172025 (number of patients in thousands) Table 08. Medical tourism market for cardiovascular treatment, by region, 20172025 ($million) Table 09. Medical tourism market for cardiovascular treatment, by region, 20172025 (number of patients in thousands) Table 10. Medical tourism market for orthopedic treatment, by region, 20172025 ($million) Table 11. Medical tourism market for orthopedic treatment, by region, 20172025 (number of patients in thousands) Table 12. Medical tourism market for neurological treatment, by region, 20172025 ($million) Table 13. Medical tourism market for neurological treatment, by region, 20172025 (number of patients in thousands) Table 14. Medical tourism market for cancer treatment, by region, 20172025 ($million) Table 15. Medical tourism market for cancer treatment, by region, 20172025 (number of patients in thousands) Table 16. Medical tourism market for fertility treatment, by region, 20172025 ($million) Table 17. Medical tourism market for fertility treatment, by region, 20172025 (number of patients in thousands) Table 18. Medical tourism market for other treatments, by region, 20172025 ($million) Table 19. Medical tourism market for other treatments, by region, 20172025 (number of patients in thousands) Table 20. Medical tourism market revenue, by region, 20172025 ($million) Table 21. Medical tourism market revenue, by region, 20172025 (number of patients in thousands) Table 22. North america medical tourism market, by country, 20172025 ($million) Table 23. North america medical tourism market, by country, 20172025 (number of patients in thousands) Table 24. North america medical tourism market, by treatment, 20172025 ($million) Table 25. North america medical tourism market, by treatment, 20172025 (number of patients in thousands) Table 26. Europe medical tourism market, by country, 20172025 ($million) Table 27. Europe medical tourism market, by country, 20172025 (number of patients in thousands) Table 28. Europe medical tourism market, by treatment, 20172025 ($million) Table 29. Europe medical tourism market, by treatment, 20172025 (number of patients in thousands) Table 30. Asia-pacific medical tourism market, by country, 20172025 ($million) Table 31. Asia-pacific medical tourism market, by country, 20172025 (number of patients in thousands) Table 32. Asia-pacific medical tourism market, by treatment, 20172025 ($million) Table 33. Asia-pacific medical tourism market, by treatment, 20172025 (number of patients in thousands) Table 34. Lamea medical tourism market, by country, 20172025 ($million) Table 35. Lamea medical tourism market, by country, 20172025 (number of patients in thousands) Table 36. Lamea medical tourism market, by treatment, 20172025 ($million) Table 37. Lamea medical tourism market, by treatment, 20172025 (number of patients in thousands) Table 38. Apollo hospitals: company snapshot Table 39. Apollo hospitals: operating segments Table 40. Apollo hospitals: product portfolio Table 41. Fortis healthcare: company snapshot Table 42. Fortis healthcare: operating segments Table 43. Fortis healthcare: product portfolio Table 44. Ahi: company snapshot Table 45. Ahi: operating segments Table 46. Ahi: product portfolio Table 47. Kpj: company snapshot Table 48. Kpj: operating segments Table 49. Kpj: product portfolio Table 50. Ntt medical center: company snapshot Table 51. Ntt medical center: operating segments Table 52. Seoul national university hospital: company snapshot Table 53. Seoul national university hospital: operating segments Table 54. Seoul national university hospital: product portfolio Table 55. Uz leuven: company snapshot Table 56. Uz leuven: operating segments Table 57. Uz leuven: product portfolio Table 58. Wooridul spine hospital: company snapshot Table 59. Perkinelmer: product portfolio Table 60. Aditya birla memorial hospital: company snapshot Table 61. Aditya birla memorial hospital: product segments Table 62. Aditya birla memorial hospital: product portfolio Table 63. Barbados fertility centre: company snapshot Table 64. Barbados fertility centre: operating segments Table 65. Barbados fertility centre: product portfolio Table 66. Prince court medical centre: company snapshot Table 67. Prince court medical centre: operating segments Table 68. Prince court medical centre: product portfolio Table 69. Samitivej hospital: company snapshot Table 70. Samitivej hospital: operating segments Table 71. Samitivej hospital: product portfolio
Figure 01. Global medical tourism market segmentation Figure 02. Top investment pockets Figure 03. Top winning strategies, by year, 20142018 Figure 04. Top winning strategies, 20152018 Figure 05. Top winning strategies: nature and type, 20142018 Figure 06. Top player positioning, 2017 Figure 07. High barganing power of buyers Figure 08. Moderate barganing power of suppliers Figure 09. Moderate threat of substitution Figure 10. Moderate threat of new entrants Figure 11. Moderate competitive rivalry Figure 12. Impact analyses Figure 13. U.s. medical tourism market, 20172025 ($million) Figure 14. U.s. medical tourism market, 20172025 (number of patients in thousands) Figure 15. Canada medical tourism market, 20172025 ($million) Figure 16. Canada medical tourism market, 20172025 (number of patients in thousands) Figure 17. Mexico medical tourism market, 20172025 ($million) Figure 18. Mexico medical tourism market, 20172025 (number of patients in thousands) Figure 19. Uk medical tourism market, 20172025 ($million) Figure 20. Uk medical tourism market, 20172025 (number of patients in thousands) Figure 21. Germany medical tourism market, 20172025 ($million) Figure 22. Germany medical tourism market, 20172025 (number of patients in thousands) Figure 23. France medical tourism market, 20172025 ($million) Figure 24. France medical tourism market, 20172025 (number of patients in thousands) Figure 25. Italy medical tourism market, 20172025 ($million) Figure 26. Italy medical tourism market, 20172025 (number of patients in thousands) Figure 27. Spain medical tourism market, 20172025 ($million) Figure 28. Spain medical tourism market, 20172025 (number of patients in thousands) Figure 29. Rest of europe medical tourism market, 20172025 ($million) Figure 30. Rest of europe medical tourism market, 20172025 (number of patients in thousands) Figure 31. India medical tourism market, 20172025 ($million) Figure 32. India medical tourism market, 20172025 (number of patients in thousands) Figure 33. China medical tourism market, 20172025 ($million) Figure 34. China medical tourism market, 20172025 (number of patients in thousands) Figure 35. Indonesia medical tourism market, 20172025 ($million) Figure 36. Indonesia medical tourism market, 20172025 (number of patients in thousands) Figure 37. Singapore medical tourism market, 20172025 ($million) Figure 38. Singapore medical tourism market, 20172025 (number of patients in thousands) Figure 39. Malaysia medical tourism market, 20172025 ($million) Figure 40. Malaysia medical tourism market, 20172025 (number of patients in thousands) Figure 41. Thailand medical tourism market, 20172025 ($million) Figure 42. Thailand medical tourism market, 20172025 (number of patients in thousands) Figure 43. South korea medical tourism market, 20172025 ($million) Figure 44. South korea medical tourism market, 20172025 (number of patients in thousands) Figure 45. Taiwan medical tourism market, 20172025 ($million) Figure 46. Taiwan medical tourism market, 20172025 (number of patients in thousands) Figure 47. Rest of europe medical tourism market, 20172025 ($million) Figure 48. Rest of europe medical tourism market, 20172025 (number of patients in thousands) Figure 49. Brazil medical tourism market, 20172025 ($million) Figure 50. Brazil medical tourism market, 20172025 (number of patients in thousands) Figure 51. Venezuela medical tourism market, 20172025 ($million) Figure 52. Venezuela medical tourism market, 20172025 (number of patients in thousands) Figure 53. Costa rica medical tourism market, 20172025 ($million) Figure 54. Costa rica medical tourism market, 20172025 (number of patients in thousands) Figure 55. Uae medical tourism market, 20172025 ($million) Figure 56. Uae medical tourism market, 20172025 (number of patients in thousands) Figure 57. South africa medical tourism market, 20172025 ($million) Figure 58. South africa medical tourism market, 20172025 (number of patients in thousands) Figure 59. Rest of europe medical tourism market, 20172025 ($million) Figure 60. Rest of europe medical tourism market, 20172025 (number of patients in thousands) Figure 61. Apollo hospitals: net sales, 20152017 ($million) Figure 62. Fortis healthcare: revenue, 20152017 ($million) Figure 63. Fortis healthcare: revenue share by region, 2017 (%) Figure 64. Kpj: net sales, 20152017 ($million) Figure 65. Kpj: revenue share by segment, 2017 (%)
UK : +44 141 628 9353 US : +1 970 279 4295
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics